公司資料
Catalent 股價、新聞與催化劑
- 股票代碼:
- CTLT
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for CTLT.
公司概覽
業務概覽
Catalent was a pharmaceutical development and delivery company that supported drug formulation, manufacturing, and packaging before being acquired and taken private. It played a major role in outsourced pharma and biotech operations.
所在地與產業分類
Catalent was headquartered in the United States and traded on NYSE before the acquisition. It sat in contract development and manufacturing rather than therapeutics.
商業模式特徵
The company generated revenue from manufacturing, development, fill-finish, and delivery services for pharma customers. Investors historically watched outsourcing demand, production utilization, and margin recovery.
生技產業定位
Catalent was a major infrastructure name for biotech and pharma, especially in manufacturing and delivery services. Because it has been acquired, it now belongs to historical sector infrastructure rather than the live public-company universe.
未來催化劑
- Catalent’s near-term catalysts are still transaction-related, with integration, divestiture, and site-rationalization milestones doing most of the work. That matters because demand only becomes valuable if the company can actually deliver at scale. Any improvement in supply or capacity can change how investors think about the next leg of the revenue curve.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。